Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Duller, D; Stiegler, P; Schweiger, M; Kahn, J; Kniepeiss, D; Jakoby, E; Tscheliessnigg, K; Iberer, F.
Sensitive serum parameters for hepatocellular carcinoma recurrence monitoring after liver transplantation: a case report.
Transplant Proc. 2007; 39(10): 3281-3283.
Doi: 10.1016/j.transproceed.2007.04.030
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Wagner Doris
- Co-Autor*innen der Med Uni Graz
-
Iberer Florian
-
Jakoby Estrella
-
Kahn Judith
-
Kniepeiss Daniela
-
Schaffellner Silvia
-
Schweiger Martin
-
Stiegler Philipp
-
Tscheliessnigg Karlheinz
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Liver cell malignancy can be seen as one of the most common indications for hepatic transplantation, but the recurrence potential of the disease significantly limits its beneficial effects. Hepatic factors influencing the recurrence rate, such as nodule size and criteria wherein transplantations are expedited, are still investigated. Pretransplant intraarterial or percutaneous treatment seem to be predictive for recurrence-free patient survival. Early detection of malignancies via serum parameters as a prognostic factor seems promising. This article reports a special case, where despite an elevated, sensitive, serum marker profile, no HCC recurrence was detected over a 2-year follow-up.
- Find related publications in this database (using NLM MeSH Indexing)
-
Aspartate Aminotransferases - blood
-
Carcinoma, Hepatocellular - complications Carcinoma, Hepatocellular - surgery
-
Female -
-
Hepatitis C - complications Hepatitis C - surgery
-
Humans -
-
Immunosuppressive Agents - therapeutic use
-
Liver Neoplasms - complications Liver Neoplasms - immunology Liver Neoplasms - surgery
-
Liver Transplantation -
-
Middle Aged -
-
Recurrence -
-
Sensitivity and Specificity -
-
Tumor Markers, Biological - blood
-
alpha-Fetoproteins - analysis